| Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets | Frank Vinluan | 03/04/20 | New York |
| Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial | Ryan McBride | 01/26/09 | Boston |
| Targanta Gets $42M Buyout Offer From NJ Drug Firm | Ryan McBride | 01/13/09 | Boston |
| Targanta Cuts 75 Percent of Staff | Wade Roush | 12/18/08 | Boston |
| Targanta Faces New Challenges to Raise Cash After FDA Shoots Down the Firm’s Antibiotic | Ryan McBride | 12/10/08 | Boston |
| FDA Declines Approval of Targanta Antibiotic | Ryan McBride | 12/09/08 | Boston |
| Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event | Ryan McBride | 12/04/08 | Boston |
| Targanta-Cubist Rivalry Brews on FDA Review of Targanta Drug | Ryan McBride | 11/18/08 | Boston |
| Targanta Releases Antibiotic Data | Ryan McBride | 10/22/08 | Boston |
| Trius Therapeutics, Developer of Antibiotic Against MRSA, Taking On Pfizer’s Zyvox | Luke Timmerman | 10/20/08 | San Diego |
| Targanta Preps For FDA Advisory Panel on New Antibiotic | Luke Timmerman | 10/14/08 | Boston |
| Targanta Aims to “Simplifi” Treatment of Deadly Bugs With Single-Shot Antibiotic | Luke Timmerman | 09/22/08 | Boston |
| Targanta Antibiotic Shown Effective in Less-Frequent Dose | Luke Timmerman | 09/02/08 | Boston |
